This video is part of the Metastatic Breast Cancer Alliance's Here All Year campaign. Breast Cancer Awareness Month is just October, but we're Here All Year.
Kris Blake went through six years of testing before receiving her Lobular Breast Cancer diagnosis. Her cancer was present during her first tests in 2013, but doctors and tests missed diagnosing until 2018. Because of that experience, she is passionate about advocating for MBC and Lobular Breast Cancer patients. Kris says, “If I can help one person to understand lobular breast cancer a little better, I would feel like I’ve made a contribution to this cause.”
Invasive lobular carcinoma (ILC) is a distinct subtype of breast cancer with unique cellular structures, biology, and behavior. ILC is the 2nd most common type of breast cancer and accounts for up to 15% of all breast cancers including mixed ductal /lobular. 90% of lobular breast cancers are ER/PR+ HER2-, although there are subpopulations that are ER/PR negative, triple negative, or HER2+.
The Metastatic Breast Cancer Alliance strives to ensure that all metastatic breast cancer patients and their caregivers know how to and are able to access the care and services they need from a responsive and well-informed healthcare system. We are doing that by working to build understanding of Metastatic Breast Cancer and how it differs from early stage breast cancer among those diagnosed—as well as their families, health care providers, researchers, and health policy makers and influencers.
Each month, our Here All Year campaign explores a new topic around metastatic breast cancer—from myth and stigma busters, to new research and strategies for improving outcomes. Want to help make a difference for people living with MBC, all year long? Dig deeper into the research, explore the available resources and share them on your social and email channels.
